2025-07-22 13:31:37,004 - __main__                       - INFO     - [3934356070.py:159] - Application started.
2025-07-22 13:31:37,005 - rfiprocessor.db.database       - INFO     - [database.py:34] - Initializing database and creating tables if they don't exist...
2025-07-22 13:31:37,012 - rfiprocessor.db.database       - INFO     - [database.py:41] - Database initialization complete.
2025-07-22 13:31:37,014 - __main__                       - INFO     - [3934356070.py:27] - --- Starting Markdown Conversion Pipeline ---
2025-07-22 13:31:38,496 - rfiprocessor.services.llm_provider - INFO     - [llm_provider.py:27] - Initialized Fast LLM Provider: gpt-4-turbo
2025-07-22 13:31:38,498 - rfiprocessor.services.prompt_loader - INFO     - [prompt_loader.py:38] - Loading prompt 'document_classifier' from: rfiprocessor\prompts\document_classifier.txt
2025-07-22 13:31:38,511 - rfiprocessor.core.agents.document_classifier - INFO     - [document_classifier.py:40] - DocumentClassifierAgent initialized successfully.
2025-07-22 13:31:38,513 - rfiprocessor.utils.wlak_dir    - DEBUG    - [wlak_dir.py:24] - Found file: data/raw/incoming\.DS_Store
2025-07-22 13:31:38,514 - rfiprocessor.utils.wlak_dir    - DEBUG    - [wlak_dir.py:24] - Found file: data/raw/incoming\Cogstate Quality Management System_Quality Questionnaire Blank.pdf
2025-07-22 13:31:38,515 - rfiprocessor.utils.wlak_dir    - DEBUG    - [wlak_dir.py:24] - Found file: data/raw/incoming\Diligent Pharma - Harmony Biosciences Core RFI 3.0 - 27-01-2025 Blank.xlsx
2025-07-22 13:31:38,516 - rfiprocessor.utils.wlak_dir    - DEBUG    - [wlak_dir.py:24] - Found file: data/raw/incoming\LEXEO GCP service provider audit questionnaire Blank.docx
2025-07-22 13:31:38,518 - __main__                       - INFO     - [3934356070.py:43] - Found 4 files. Registering new files in the database...
2025-07-22 13:31:38,539 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:55] - Added new document '.DS_Store' to database with ID 11.
2025-07-22 13:31:38,547 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:55] - Added new document 'Cogstate Quality Management System_Quality Questionnaire Blank.pdf' to database with ID 12.
2025-07-22 13:31:38,553 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:55] - Added new document 'Diligent Pharma - Harmony Biosciences Core RFI 3.0 - 27-01-2025 Blank.xlsx' to database with ID 13.
2025-07-22 13:31:38,561 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:55] - Added new document 'LEXEO GCP service provider audit questionnaire Blank.docx' to database with ID 14.
2025-07-22 13:31:38,563 - rfiprocessor.services.db_handler - DEBUG    - [db_handler.py:68] - Querying for documents with status: PENDING
2025-07-22 13:31:38,566 - __main__                       - INFO     - [3934356070.py:61] - Found 3 new documents to process.
2025-07-22 13:31:38,602 - __main__                       - INFO     - [3934356070.py:66] - Processing document: Cogstate Quality Management System_Quality Questionnaire Blank.pdf (ID: 12)
2025-07-22 13:31:38,602 - rfiprocessor.services.markdown_converter - INFO     - [markdown_converter.py:39] - Converting file: data/raw/incoming\Cogstate Quality Management System_Quality Questionnaire Blank.pdf with markitdown
2025-07-22 13:31:39,208 - rfiprocessor.services.markdown_converter - INFO     - [markdown_converter.py:111] - Saved markdown to: data\markdown\incoming\Cogstate Quality Management System_Quality Questionnaire Blank.md
2025-07-22 13:31:39,215 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 12 with: {'markdown_filepath': 'data\\markdown\\incoming\\Cogstate Quality Management System_Quality Questionnaire Blank.md', 'processed_filepath': 'data/raw/processed\\Cogstate Quality Management System_Quality Questionnaire Blank.pdf', 'ingestion_status': <IngestionStatus.MARKDOWN_CONVERTED: 'MARKDOWN_CONVERTED'>, 'error_message': None}
2025-07-22 13:31:39,223 - __main__                       - INFO     - [3934356070.py:92] - Successfully converted and moved document ID 12.
2025-07-22 13:31:39,228 - __main__                       - INFO     - [3934356070.py:66] - Processing document: Diligent Pharma - Harmony Biosciences Core RFI 3.0 - 27-01-2025 Blank.xlsx (ID: 13)
2025-07-22 13:31:39,230 - rfiprocessor.services.markdown_converter - INFO     - [markdown_converter.py:39] - Converting file: data/raw/incoming\Diligent Pharma - Harmony Biosciences Core RFI 3.0 - 27-01-2025 Blank.xlsx with unstructured
2025-07-22 13:31:39,785 - rfiprocessor.services.markdown_converter - ERROR    - [markdown_converter.py:93] - Unstructured processing failed: No module named 'msoffcrypto'
2025-07-22 13:31:39,787 - rfiprocessor.services.markdown_converter - ERROR    - [markdown_converter.py:59] - Conversion failed: No module named 'msoffcrypto'
2025-07-22 13:31:39,787 - __main__                       - ERROR    - [3934356070.py:95] - Error processing document ID 13 ('Diligent Pharma - Harmony Biosciences Core RFI 3.0 - 27-01-2025 Blank.xlsx'): No module named 'msoffcrypto'
Traceback (most recent call last):
  File "C:\Users\omars\AppData\Local\Temp\ipykernel_108484\3934356070.py", line 74, in run_markdown_conversion_pipeline
    markdown_content, markdown_path = converter.convert_to_markdown(
                                      ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~^
        file_path=doc.source_filepath,
        ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
        processor=processor_to_use
        ^^^^^^^^^^^^^^^^^^^^^^^^^^
    )
    ^
  File "c:\Users\omars\Documents\UST\Cogstate-RFI\Cogstate-RFI\rfiprocessor\services\markdown_converter.py", line 46, in convert_to_markdown
    markdown_content = self._process_with_unstructured(file_path)
  File "c:\Users\omars\Documents\UST\Cogstate-RFI\Cogstate-RFI\rfiprocessor\services\markdown_converter.py", line 74, in _process_with_unstructured
    elements = partition(file_path)
  File "c:\Users\omars\Documents\UST\Cogstate-RFI\.venv\Lib\site-packages\unstructured\partition\auto.py", line 291, in partition
    partition = partitioner_loader.get(file_type)
  File "c:\Users\omars\Documents\UST\Cogstate-RFI\.venv\Lib\site-packages\unstructured\partition\auto.py", line 364, in get
    self._partitioners[file_type] = self._load_partitioner(file_type)
                                    ~~~~~~~~~~~~~~~~~~~~~~^^^^^^^^^^^
  File "c:\Users\omars\Documents\UST\Cogstate-RFI\.venv\Lib\site-packages\unstructured\partition\auto.py", line 382, in _load_partitioner
    partitioner_module = importlib.import_module(file_type.partitioner_module_qname)
  File "C:\Program Files\Python313\Lib\importlib\__init__.py", line 88, in import_module
    return _bootstrap._gcd_import(name[level:], package, level)
           ~~~~~~~~~~~~~~~~~~~~~~^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
  File "<frozen importlib._bootstrap>", line 1387, in _gcd_import
  File "<frozen importlib._bootstrap>", line 1360, in _find_and_load
  File "<frozen importlib._bootstrap>", line 1331, in _find_and_load_unlocked
  File "<frozen importlib._bootstrap>", line 935, in _load_unlocked
  File "<frozen importlib._bootstrap_external>", line 1026, in exec_module
  File "<frozen importlib._bootstrap>", line 488, in _call_with_frames_removed
  File "c:\Users\omars\Documents\UST\Cogstate-RFI\.venv\Lib\site-packages\unstructured\partition\xlsx.py", line 11, in <module>
    from msoffcrypto import OfficeFile
ModuleNotFoundError: No module named 'msoffcrypto'
2025-07-22 13:31:39,884 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 13 with: {'ingestion_status': <IngestionStatus.FAILED: 'FAILED'>, 'error_message': "No module named 'msoffcrypto'"}
2025-07-22 13:31:39,893 - __main__                       - INFO     - [3934356070.py:66] - Processing document: LEXEO GCP service provider audit questionnaire Blank.docx (ID: 14)
2025-07-22 13:31:39,895 - rfiprocessor.services.markdown_converter - INFO     - [markdown_converter.py:39] - Converting file: data/raw/incoming\LEXEO GCP service provider audit questionnaire Blank.docx with markitdown
2025-07-22 13:31:41,808 - rfiprocessor.services.markdown_converter - INFO     - [markdown_converter.py:111] - Saved markdown to: data\markdown\incoming\LEXEO GCP service provider audit questionnaire Blank.md
2025-07-22 13:31:41,814 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 14 with: {'markdown_filepath': 'data\\markdown\\incoming\\LEXEO GCP service provider audit questionnaire Blank.md', 'processed_filepath': 'data/raw/processed\\LEXEO GCP service provider audit questionnaire Blank.docx', 'ingestion_status': <IngestionStatus.MARKDOWN_CONVERTED: 'MARKDOWN_CONVERTED'>, 'error_message': None}
2025-07-22 13:31:41,821 - __main__                       - INFO     - [3934356070.py:92] - Successfully converted and moved document ID 14.
2025-07-22 13:31:41,823 - __main__                       - INFO     - [3934356070.py:108] - --- Markdown Conversion Pipeline Finished ---
2025-07-22 13:31:41,824 - __main__                       - INFO     - [3934356070.py:117] - --- Starting Document Classification Step ---
2025-07-22 13:31:41,824 - rfiprocessor.services.db_handler - DEBUG    - [db_handler.py:68] - Querying for documents with status: MARKDOWN_CONVERTED
2025-07-22 13:31:41,828 - __main__                       - INFO     - [3934356070.py:123] - Found 2 documents to classify.
2025-07-22 13:31:41,831 - __main__                       - INFO     - [3934356070.py:127] - Classifying document: Cogstate Quality Management System_Quality Questionnaire Blank.pdf (ID: 12)
2025-07-22 13:31:41,848 - rfiprocessor.core.agents.document_classifier - INFO     - [document_classifier.py:59] - Attempting to classify document...
2025-07-22 13:31:44,016 - rfiprocessor.core.agents.document_classifier - DEBUG    - [document_classifier.py:68] - LLM raw response for classification: {
  "document_type": "RFI/RFP",
  "document_grade": "Past Response"
}
2025-07-22 13:31:44,017 - rfiprocessor.core.agents.document_classifier - INFO     - [document_classifier.py:77] - Document classified successfully as: {'document_type': 'RFI/RFP', 'document_grade': 'Past Response'}
2025-07-22 13:31:44,019 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 12 with: {'document_type': 'RFI/RFP', 'document_grade': 'Past Response', 'ingestion_status': <IngestionStatus.CLASSIFIED: 'CLASSIFIED'>, 'error_message': None}
2025-07-22 13:31:44,026 - __main__                       - INFO     - [3934356070.py:144] - Successfully classified document ID 12.
2025-07-22 13:31:44,029 - __main__                       - INFO     - [3934356070.py:127] - Classifying document: LEXEO GCP service provider audit questionnaire Blank.docx (ID: 14)
2025-07-22 13:31:44,041 - rfiprocessor.core.agents.document_classifier - INFO     - [document_classifier.py:59] - Attempting to classify document...
2025-07-22 13:31:45,712 - rfiprocessor.core.agents.document_classifier - DEBUG    - [document_classifier.py:68] - LLM raw response for classification: {
  "document_type": "RFI/RFP",
  "document_grade": "Past Response"
}
2025-07-22 13:31:45,713 - rfiprocessor.core.agents.document_classifier - INFO     - [document_classifier.py:77] - Document classified successfully as: {'document_type': 'RFI/RFP', 'document_grade': 'Past Response'}
2025-07-22 13:31:45,715 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 14 with: {'document_type': 'RFI/RFP', 'document_grade': 'Past Response', 'ingestion_status': <IngestionStatus.CLASSIFIED: 'CLASSIFIED'>, 'error_message': None}
2025-07-22 13:31:45,720 - __main__                       - INFO     - [3934356070.py:144] - Successfully classified document ID 14.
2025-07-22 13:31:45,722 - __main__                       - INFO     - [3934356070.py:155] - --- Ingestion Pipeline Finished ---
2025-07-22 13:31:45,722 - __main__                       - INFO     - [3934356070.py:167] - Application finished.
2025-07-22 13:31:45,738 - __main__                       - INFO     - [3136344587.py:72] - Application started.
2025-07-22 13:31:45,740 - rfiprocessor.db.database       - INFO     - [database.py:34] - Initializing database and creating tables if they don't exist...
2025-07-22 13:31:45,743 - rfiprocessor.db.database       - INFO     - [database.py:41] - Database initialization complete.
2025-07-22 13:31:45,746 - rfiprocessor.services.llm_provider - INFO     - [llm_provider.py:27] - Initialized Fast LLM Provider: gpt-4-turbo
2025-07-22 13:31:45,747 - rfiprocessor.services.prompt_loader - DEBUG    - [prompt_loader.py:34] - Returning cached prompt: 'document_classifier'
2025-07-22 13:31:45,749 - rfiprocessor.core.agents.document_classifier - INFO     - [document_classifier.py:40] - DocumentClassifierAgent initialized successfully.
2025-07-22 13:31:45,749 - __main__                       - INFO     - [3136344587.py:31] - --- Starting Document Classification Step ---
2025-07-22 13:31:45,750 - rfiprocessor.services.db_handler - DEBUG    - [db_handler.py:68] - Querying for documents with status: MARKDOWN_CONVERTED
2025-07-22 13:31:45,752 - __main__                       - INFO     - [3136344587.py:35] - No new documents to classify.
2025-07-22 13:31:45,755 - __main__                       - INFO     - [3136344587.py:69] - --- Ingestion Pipeline Finished ---
2025-07-22 13:31:45,756 - __main__                       - INFO     - [3136344587.py:80] - Application finished.
2025-07-22 13:31:45,782 - __main__                       - INFO     - [4134370656.py:107] - Application started.
2025-07-22 13:31:45,783 - rfiprocessor.db.database       - INFO     - [database.py:34] - Initializing database and creating tables if they don't exist...
2025-07-22 13:31:45,784 - rfiprocessor.db.database       - INFO     - [database.py:41] - Database initialization complete.
2025-07-22 13:31:45,785 - __main__                       - INFO     - [4134370656.py:26] - --- Starting RFI Parsing Pipeline ---
2025-07-22 13:31:46,303 - rfiprocessor.services.llm_provider - INFO     - [llm_provider.py:54] - Initialized Advanced LLM Provider: gpt-4o
2025-07-22 13:31:46,305 - rfiprocessor.services.prompt_loader - INFO     - [prompt_loader.py:38] - Loading prompt 'rfi_parser_summary' from: rfiprocessor\prompts\rfi_parser_summary.txt
2025-07-22 13:31:46,319 - rfiprocessor.services.prompt_loader - INFO     - [prompt_loader.py:38] - Loading prompt 'rfi_parser_chunking' from: rfiprocessor\prompts\rfi_parser_chunking.txt
2025-07-22 13:31:46,337 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:51] - RfiParserAgent initialized successfully.
2025-07-22 13:31:46,338 - __main__                       - INFO     - [4134370656.py:35] - --- Starting RFI/RFP Parsing Step ---
2025-07-22 13:31:46,339 - rfiprocessor.services.db_handler - DEBUG    - [db_handler.py:68] - Querying for documents with status: CLASSIFIED
2025-07-22 13:31:46,340 - __main__                       - INFO     - [4134370656.py:41] - Found 2 documents to potentially parse.
2025-07-22 13:31:46,343 - __main__                       - INFO     - [4134370656.py:51] - Parsing RFI/RFP document: Cogstate Quality Management System_Quality Questionnaire Blank.pdf (ID: 12)
2025-07-22 13:31:46,345 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:135] - Generating executive summary...
2025-07-22 13:32:18,616 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:138] - Splitting document into processable chunks...
2025-07-22 13:32:18,618 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:145] - Processing 5 chunks concurrently...
2025-07-22 13:32:30,067 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': 'AbbVie R&D QA Supplier Assessment Quality Questionnaire', 'qa_pairs': [{'question': 'Are activities performed attributable to a specific user?', 'answer': '', 'domain': 'Security', 'type': 'close-ended'}, {'question': 'Are changes to records prohibited except by authorized users?', 'answer': '', 'domain': 'Security', 'type': 'close-ended'}, {'question': 'Are Good Documentation Practices followed for changes to records and data, including electronic records?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are audit trails enabled to allow for reconstruction of the course of events relating to the creation, modification, or deletion of an electronic record?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are records reviewed for accuracy, completeness, and compliance with established procedures and regulations?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Is data maintained securely from the time of creation through disposition after the record’s retention period?', 'answer': '', 'domain': 'Security', 'type': 'close-ended'}, {'question': "Does audit trail review for electronic data and the frequency with which it's conducted ensure that regulatory requirements are met, appropriate change controls are implemented, and the reliability of the review is verified?", 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are electronic source records retained even when printouts are used to present data?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have an established Disaster Recovery Plan (DRP)?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'If no, provide an explanation.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'If yes, does the plan include up to date contact information for Disaster Recovery service providers?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'Provide the date of when the DRP was last reviewed.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Provide the date of when the DRP was last tested.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Does your company have an established Business Continuity Plan (BCP)?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'If no, explain how the business will ensure they can restore operations in case of unforeseen events with minimal impact on the services provided.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'If yes, does the plan include up to date contact information for Business Continuity service providers?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'Provide the date of when the BCP was last reviewed.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Provide the date of when the BCP was last tested.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}], 'meta_data': {'company_name': 'AbbVie', 'date': 'N/A', 'category': 'RFP', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:32:33,335 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': 'The purpose of this Quality Questionnaire (QQ) is to obtain a comprehensive understanding of the business practices, procedures, and quality systems currently in place at your company. Please ensure you respond to all questions and indicate N/A where appropriate. If any question requires additional space, please attach a supplemental page. All responses to this questionnaire are treated as highly confidential and will solely be utilized by AbbVie Quality Assurance (QA) Representatives as an assessment tool. To facilitate the assessment process, we ask that following documents be provided with the completed QQ: Quality Manual, Quality Policy, Organizational Charts, SOP/Policies/Work Instruction Indices, including titles and effective dates, Copies of current licenses, registrations, certifications, and/or accreditations, Listing of equipment and instruments used and/or maintained, if applicable. We kindly ask that you complete the Quality Questionnaire within 14 calendar days of receiving this request. Please do not hesitate to reach out for any questions regarding the assessment process. Thank you for your cooperation. AbbVie QA Representatives', 'description': "The Quality Questionnaire aims to gather detailed information about the company's quality systems and business practices. It includes questions about company structure, regulatory adherence, audits, and quality policies. Respondents are required to provide various documents such as Quality Manuals and Organizational Charts to support their responses.", 'qa_pairs': [{'question': 'Is your company a division or subsidiary of another corporation?', 'answer': '', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Is the company address the location where services will be performed?', 'answer': '', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Will any part of the services be sub-contracted to another provider?', 'answer': '', 'domain': 'General', 'type': 'close-ended'}, {'question': 'List any contracts and/or quality agreements that include quality oversight responsibilities for services to be provided.', 'answer': '', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What regulatory guidelines does your company adhere to at its locations for the services it provides?', 'answer': '', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your company verify that it does not use, in any capacity, the services of any person on the FDA Debarment List or an equivalent for other International Authorities?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Has your company been audited or inspected in the past 2 years?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Audited/Inspected by any of the following Regulatory or Government agencies: Food and Drug Administration (FDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), or other agency?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Audited/Inspected by any of the following Certification or Accreditation agencies: International Standards Organization (ISO), National Research Council (NRC), Clinical Laboratory Improvement Amendments (CLIA), Accreditation of Human Research Protection Programs (AAHRPP), or other agency?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Would your company be receptive to an onsite or remote audit by AbbVie QA Representatives?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Organization?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a defined Quality Policy for ensuring quality in the services provided?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}], 'meta_data': {'company_name': 'AbbVie', 'date': 'N/A', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:32:35,813 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': 'N/A', 'description': 'AbbVie R&D QA Supplier Assessment Quality Questionnaire', 'qa_pairs': [{'question': 'Audited/Inspected by any of the following Certification or Accreditation agencies: International Standards Organization (ISO), National Research Council (NRC), Clinical Laboratory Improvement Amendments (CLIA), Accreditation of Human Research Protection Programs (AAHRPP), or other agency?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Would your company be receptive to an onsite or remote audit by AbbVie QA Representatives?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Organization?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a defined Quality Policy for ensuring quality in the services provided?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Manual that outlines the approach to quality?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Management System (QMS) in place to ensure quality in the execution of service-related activities?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your QMS require written procedures to be approved and reviewed periodically by the Quality Organization?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'If your company has multiple locations, are all systems/policies/procedures utilized globally across the organization?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your QMS include a Management Review process in which the effectiveness of the Quality System is reviewed by Executive Management?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your QMS include an Internal Audit Program?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Are internal audits conducted on a routine basis according to a documented and maintained schedule?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Are corrective actions taken when any audit deficiencies are identified?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Are audit outcomes for both internal and external/customer audits part of the agenda for Management Review?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Describe the Quality System’s Risk Management process.', 'answer': 'N/A', 'domain': 'Quality', 'type': 'open-ended'}, {'question': 'Describe how risks are communicated to stakeholders (e.g., users, medical professionals, regulatory bodies, etc).', 'answer': 'N/A', 'domain': 'Quality', 'type': 'open-ended'}, {'question': 'Does your company have a written training program including procedures for execution and documentation of required training?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Approved job descriptions for all employees?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Management of current CVs?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Comprehensive training requirements for all job titles or functions?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Routine review of job descriptions, CVs, and training requirements of all job titles?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Regulatory training requirements?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Documentation of training, including On the Job training?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Do all employees performing regulated activities/services receive annual refresher training on the applicable GxP Guidelines?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Are all procedures, forms, and electronic systems readily available to all employees performing activities related to the services provided?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Will any contract employees be performing activities related to the services provided?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company have a process and written procedures for establishing and maintaining control of quality documents and records?', 'answer': 'N/A', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'Are quality documents controlled by revision and/or date?', 'answer': 'N/A', 'domain': 'Documentation', 'type': 'close-ended'}], 'meta_data': {'company_name': 'AbbVie', 'date': 'N/A', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:32:39,425 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': '', 'qa_pairs': [{'question': 'Do you have audit outcomes?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include the evaluation of risk?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include root cause analysis?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include impact on data?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include escalation process?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include effectiveness check?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the Quality Organization review and approve exception documentation?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Is there a provision to notify the customer in a timely manner and/or request a deviation from requirements or protocols?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Is there a process for tracking and trending CAPA issues and exceptions?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are exceptions and/or CAPAs part of the agenda for Management Review?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a change management process and written procedures for change control?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does the change management system prevent unauthorized modifications to validated systems, processes, and equipment?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does the change management process ensure that documents impacted by changes are promptly revised?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Are proposed changes reviewed and approved by the Quality Organization and appropriate Functional Area Representatives?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does the change management process require notification to customers for changes that may have impact on the service-related activities provided?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does your company utilize any computerized systems in support of QMS activities?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Does your company require validation?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Provide the following details for any validated computerized systems utilized in support of QMS activities: System Name, Intended Use, Annex 11/21 CFR Part 11 Compliant.', 'answer': '', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Are validated electronic systems only accessible by authorized users with a unique user ID and password?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Are access levels implemented in the electronic systems which allow only authorized users to enter data for which they are responsible?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Is electronic data considered original data?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Are electronic signatures used in support of QMS activities?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Does your company have a Disaster Recovery Plan and Business Continuity Plan for the computerized systems used in support of QMS activities?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Are there controls in place to ensure all data is attributable, legible, contemporaneous, original, and accurate (ALCOA)?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are there controls in place to ensure that data is complete, consistent, enduring, and available (ALCOA+)?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Does your QMS require that service-related activities be documented at the time of performance?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are electronic system roles (e.g., user, administrator, reviewer) clearly defined with appropriately assigned rights and permissions?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are activities performed attributable to a specific user?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are changes to records prohibited except by authorized users?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are Good Documentation Practices followed for changes to records and data, including electronic records?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are audit trails enabled to allow for reconstruction of the course of events relating to the creation, modification, or deletion of an electronic record?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are records reviewed for accuracy, completeness, and compliance with established procedures and regulations?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Is data maintained securely from the time of creation through disposition after the record’s retention period?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}], 'meta_data': {'company_name': 'AbbVie R&D QA', 'date': '', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:32:49,887 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': 'N/A', 'description': 'AbbVie R&D QA Supplier Assessment Quality Questionnaire', 'qa_pairs': [{'question': 'F) Documentation of training, including On the Job training?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'A26. Do all employees performing regulated activities/services receive annual refresher training on the applicable GxP Guidelines?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'A27. Are all procedures, forms, and electronic systems readily available to all employees performing activities related to the services provided?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'A28. Will any contract employees be performing activities related to the services provided?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'If yes, explain how the contractor is properly trained and qualified to provide services on behalf of your company.', 'answer': '', 'domain': 'Training', 'type': 'open-ended'}, {'question': 'A29. Does your company have a process and written procedures for establishing and maintaining control of quality documents and records?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'Documentation', 'type': 'open-ended'}, {'question': 'A30. Are quality documents controlled by revision and/or date?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'If yes, are the historical files of the revised documents retrievable?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A31. Is there a record retention policy for both paper and electronic records?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A32. Are Good Documentation Practices trained on and followed?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'A33. Is there a requirement that the Quality Organization has responsibility for final approval of quality related documents?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'If yes, describe.', 'answer': '', 'domain': 'Quality', 'type': 'open-ended'}, {'question': 'A34. Does your company have a process to ensure employees are trained prior to the use of new or revised versions of documents and procedures?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'If yes, describe the process.', 'answer': '', 'domain': 'Training', 'type': 'open-ended'}, {'question': 'A35. Does your company have a system to ensure that only the correct version of documents and procedures are being used and referenced?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A36. Is there a procedure for the storage, maintenance, and retrieval of electronic and/or paper original quality documents and data?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'Documentation', 'type': 'open-ended'}, {'question': 'A37. Does your company have a process and written procedures for the selection, approval, and oversight of suppliers?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'Supplier Management', 'type': 'open-ended'}, {'question': 'A38. Is the supplier’s QMS evaluated as part of the qualification/assessment process for new and existing suppliers including compliance with applicable regulations?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A39. Is there a formal process for periodically re-evaluating the acceptability of suppliers?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'Supplier Management', 'type': 'open-ended'}, {'question': 'A40. Is periodic re-evaluation of suppliers performed according to a documented and maintained schedule?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A41. Does the periodic re-evaluation of suppliers include review of performance metrics?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A42. Does your company maintain a list of approved suppliers?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A43. Does your company have a process and written procedures for managing the following types of exceptions: A) Deviations to established procedures?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'If no, provide an explanation.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'B) Deviations to requirements for testing (e.g., testing conditions)?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'If no, provide an explanation.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'C) Deviations to established protocols?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'If no, provide an explanation.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'A44. Does your company have a Corrective Action and Preventive Action (CAPA) procedure for issues, exceptions, and audit outcomes?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'A45. Does the CAPA procedure include the following: A) Evaluation of Risk?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'B) Root Cause Analysis?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'C) Impact on Data?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'D) Escalation Process?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'E) Effectiveness Check?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A46. Does the Quality Organization review and approve exception documentation?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'A47. Is there a provision to notify the customer in a timely manner and/or request a deviation from requirements or protocols?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'A48. Is there a process for tracking and trending CAPA issues and exceptions?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A49. Are exceptions and/or CAPAs part of the agenda for Management Review?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A50. Does your company have a change management process and written procedures for change control?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'Change Management', 'type': 'open-ended'}, {'question': 'If no, explain how consistency and compliance is maintained for changes that could impact services and quality.', 'answer': '', 'domain': 'Change Management', 'type': 'open-ended'}], 'meta_data': {'company_name': 'AbbVie', 'date': 'N/A', 'category': 'RFP', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:32:49,892 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:191] - Successfully parsed document. Found 122 Q&A pairs.
2025-07-22 13:32:49,897 - __main__                       - INFO     - [4134370656.py:67] - Saved parsed output to json_output\Cogstate Quality Management System_Quality Questionnaire Blank.json
2025-07-22 13:32:49,899 - __main__                       - INFO     - [4134370656.py:73] - Successfully validated JSON structure for doc ID 12.
2025-07-22 13:32:49,902 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 12 with: {'rfi_json_payload': {'summary': "## Solution Overview\nOur proposed solution leverages cutting-edge technology and industry best practices to deliver a comprehensive platform tailored to meet the unique needs of your organization. By integrating advanced data analytics and user-friendly interfaces, we ensure that your team can efficiently manage and analyze critical information. Our solution is designed to enhance operational efficiency and drive informed decision-making.\n\n## Technical Capabilities\nThe platform is built on a robust, scalable architecture that supports seamless integration with existing systems, ensuring minimal disruption during deployment. Advanced security features are embedded throughout the system to protect sensitive data and maintain compliance with industry standards. Our technology stack includes cloud-based services that offer high availability and reliability.\n\n## Regulatory Compliance\nWe are committed to adhering to all relevant regulatory frameworks, ensuring that our solution complies with industry standards such as HIPAA, GDPR, and other applicable regulations. Our compliance team continuously monitors changes in regulatory requirements to ensure ongoing adherence and to provide peace of mind for your organization.\n\n## Implementation Timeline\nOur implementation process follows a structured timeline that includes phases for planning, development, testing, and deployment. We anticipate a full deployment within 12 weeks, with regular updates and checkpoints to ensure alignment with your objectives. Our project management approach is designed to be flexible, accommodating any necessary adjustments.\n\n## Key Differentiators\nOur solution stands out due to its user-centric design, which prioritizes ease of use and accessibility. Additionally, we offer unparalleled customer support and a commitment to continuous improvement, ensuring that our platform evolves to meet your changing needs. Our team's deep industry expertise further enhances our ability to deliver a solution that aligns with your strategic goals.\n\n## Support and Maintenance\nWe provide comprehensive support and maintenance services to ensure the ongoing success of our solution. Our dedicated support team is available 24/7 to address any issues and provide timely assistance. Regular updates and enhancements are included as part of our service commitment, ensuring that your platform remains current and effective.\n\nCompany Name: Cogstate", 'description': "The Quality Questionnaire aims to gather detailed information about the company's quality systems and business practices. It includes questions about company structure, regulatory adherence, audits, and quality policies. Respondents are required to provide various documents such as Quality Manuals and Organizational Charts to support their responses.\n\nAbbVie R&D QA Supplier Assessment Quality Questionnaire\n\nAbbVie R&D QA Supplier Assessment Quality Questionnaire\n\nAbbVie R&D QA Supplier Assessment Quality Questionnaire", 'qa_pairs': [{'question': 'Is your company a division or subsidiary of another corporation?', 'answer': '', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Is the company address the location where services will be performed?', 'answer': '', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Will any part of the services be sub-contracted to another provider?', 'answer': '', 'domain': 'General', 'type': 'close-ended'}, {'question': 'List any contracts and/or quality agreements that include quality oversight responsibilities for services to be provided.', 'answer': '', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What regulatory guidelines does your company adhere to at its locations for the services it provides?', 'answer': '', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your company verify that it does not use, in any capacity, the services of any person on the FDA Debarment List or an equivalent for other International Authorities?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Has your company been audited or inspected in the past 2 years?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Audited/Inspected by any of the following Regulatory or Government agencies: Food and Drug Administration (FDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), or other agency?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Audited/Inspected by any of the following Certification or Accreditation agencies: International Standards Organization (ISO), National Research Council (NRC), Clinical Laboratory Improvement Amendments (CLIA), Accreditation of Human Research Protection Programs (AAHRPP), or other agency?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Would your company be receptive to an onsite or remote audit by AbbVie QA Representatives?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Organization?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a defined Quality Policy for ensuring quality in the services provided?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Audited/Inspected by any of the following Certification or Accreditation agencies: International Standards Organization (ISO), National Research Council (NRC), Clinical Laboratory Improvement Amendments (CLIA), Accreditation of Human Research Protection Programs (AAHRPP), or other agency?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Would your company be receptive to an onsite or remote audit by AbbVie QA Representatives?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Organization?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a defined Quality Policy for ensuring quality in the services provided?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Manual that outlines the approach to quality?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your company have a Quality Management System (QMS) in place to ensure quality in the execution of service-related activities?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your QMS require written procedures to be approved and reviewed periodically by the Quality Organization?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'If your company has multiple locations, are all systems/policies/procedures utilized globally across the organization?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your QMS include a Management Review process in which the effectiveness of the Quality System is reviewed by Executive Management?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Does your QMS include an Internal Audit Program?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Are internal audits conducted on a routine basis according to a documented and maintained schedule?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Are corrective actions taken when any audit deficiencies are identified?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Are audit outcomes for both internal and external/customer audits part of the agenda for Management Review?', 'answer': 'N/A', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'Describe the Quality System’s Risk Management process.', 'answer': 'N/A', 'domain': 'Quality', 'type': 'open-ended'}, {'question': 'Describe how risks are communicated to stakeholders (e.g., users, medical professionals, regulatory bodies, etc).', 'answer': 'N/A', 'domain': 'Quality', 'type': 'open-ended'}, {'question': 'Does your company have a written training program including procedures for execution and documentation of required training?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Approved job descriptions for all employees?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Management of current CVs?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Comprehensive training requirements for all job titles or functions?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Routine review of job descriptions, CVs, and training requirements of all job titles?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Regulatory training requirements?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company’s training program include the following: Documentation of training, including On the Job training?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Do all employees performing regulated activities/services receive annual refresher training on the applicable GxP Guidelines?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Are all procedures, forms, and electronic systems readily available to all employees performing activities related to the services provided?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Will any contract employees be performing activities related to the services provided?', 'answer': 'N/A', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'Does your company have a process and written procedures for establishing and maintaining control of quality documents and records?', 'answer': 'N/A', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'Are quality documents controlled by revision and/or date?', 'answer': 'N/A', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'F) Documentation of training, including On the Job training?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'A26. Do all employees performing regulated activities/services receive annual refresher training on the applicable GxP Guidelines?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'A27. Are all procedures, forms, and electronic systems readily available to all employees performing activities related to the services provided?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'A28. Will any contract employees be performing activities related to the services provided?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'If yes, explain how the contractor is properly trained and qualified to provide services on behalf of your company.', 'answer': '', 'domain': 'Training', 'type': 'open-ended'}, {'question': 'A29. Does your company have a process and written procedures for establishing and maintaining control of quality documents and records?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'If yes, list applicable procedures.', 'answer': '', 'domain': 'Documentation', 'type': 'open-ended'}, {'question': 'A30. Are quality documents controlled by revision and/or date?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'If yes, are the historical files of the revised documents retrievable?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A31. Is there a record retention policy for both paper and electronic records?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A32. Are Good Documentation Practices trained on and followed?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'A33. Is there a requirement that the Quality Organization has responsibility for final approval of quality related documents?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'If yes, describe.', 'answer': '', 'domain': 'Quality', 'type': 'open-ended'}, {'question': 'A34. Does your company have a process to ensure employees are trained prior to the use of new or revised versions of documents and procedures?', 'answer': '', 'domain': 'Training', 'type': 'close-ended'}, {'question': 'If yes, describe the process.', 'answer': '', 'domain': 'Training', 'type': 'open-ended'}, {'question': 'A35. Does your company have a system to ensure that only the correct version of documents and procedures are being used and referenced?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A36. Is there a procedure for the storage, maintenance, and retrieval of electronic and/or paper original quality documents and data?', 'answer': '', 'domain': 'Documentation', 'type': 'close-ended'}, {'question': 'A37. Does your company have a process and written procedures for the selection, approval, and oversight of suppliers?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A38. Is the supplier’s QMS evaluated as part of the qualification/assessment process for new and existing suppliers including compliance with applicable regulations?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A39. Is there a formal process for periodically re-evaluating the acceptability of suppliers?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A40. Is periodic re-evaluation of suppliers performed according to a documented and maintained schedule?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A41. Does the periodic re-evaluation of suppliers include review of performance metrics?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A42. Does your company maintain a list of approved suppliers?', 'answer': '', 'domain': 'Supplier Management', 'type': 'close-ended'}, {'question': 'A43. Does your company have a process and written procedures for managing the following types of exceptions: A) Deviations to established procedures?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'If no, provide an explanation.', 'answer': '', 'domain': 'CAPA', 'type': 'open-ended'}, {'question': 'B) Deviations to requirements for testing (e.g., testing conditions)?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'C) Deviations to established protocols?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A44. Does your company have a Corrective Action and Preventive Action (CAPA) procedure for issues, exceptions, and audit outcomes?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A45. Does the CAPA procedure include the following: A) Evaluation of Risk?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'B) Root Cause Analysis?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'C) Impact on Data?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'D) Escalation Process?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'E) Effectiveness Check?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A46. Does the Quality Organization review and approve exception documentation?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'A47. Is there a provision to notify the customer in a timely manner and/or request a deviation from requirements or protocols?', 'answer': '', 'domain': 'Quality', 'type': 'close-ended'}, {'question': 'A48. Is there a process for tracking and trending CAPA issues and exceptions?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A49. Are exceptions and/or CAPAs part of the agenda for Management Review?', 'answer': '', 'domain': 'CAPA', 'type': 'close-ended'}, {'question': 'A50. Does your company have a change management process and written procedures for change control?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'If no, explain how consistency and compliance is maintained for changes that could impact services and quality.', 'answer': '', 'domain': 'Change Management', 'type': 'open-ended'}, {'question': 'Do you have audit outcomes?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include the evaluation of risk?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include root cause analysis?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include impact on data?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include escalation process?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the CAPA procedure include effectiveness check?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does the Quality Organization review and approve exception documentation?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Is there a provision to notify the customer in a timely manner and/or request a deviation from requirements or protocols?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Is there a process for tracking and trending CAPA issues and exceptions?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are exceptions and/or CAPAs part of the agenda for Management Review?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a change management process and written procedures for change control?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does the change management system prevent unauthorized modifications to validated systems, processes, and equipment?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does the change management process ensure that documents impacted by changes are promptly revised?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Are proposed changes reviewed and approved by the Quality Organization and appropriate Functional Area Representatives?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does the change management process require notification to customers for changes that may have impact on the service-related activities provided?', 'answer': '', 'domain': 'Change Management', 'type': 'close-ended'}, {'question': 'Does your company utilize any computerized systems in support of QMS activities?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Does your company require validation?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Provide the following details for any validated computerized systems utilized in support of QMS activities: System Name, Intended Use, Annex 11/21 CFR Part 11 Compliant.', 'answer': '', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Are validated electronic systems only accessible by authorized users with a unique user ID and password?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Are access levels implemented in the electronic systems which allow only authorized users to enter data for which they are responsible?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Is electronic data considered original data?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Are electronic signatures used in support of QMS activities?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Does your company have a Disaster Recovery Plan and Business Continuity Plan for the computerized systems used in support of QMS activities?', 'answer': '', 'domain': 'Technology', 'type': 'close-ended'}, {'question': 'Are there controls in place to ensure all data is attributable, legible, contemporaneous, original, and accurate (ALCOA)?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are there controls in place to ensure that data is complete, consistent, enduring, and available (ALCOA+)?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Does your QMS require that service-related activities be documented at the time of performance?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are electronic system roles (e.g., user, administrator, reviewer) clearly defined with appropriately assigned rights and permissions?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are activities performed attributable to a specific user?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are changes to records prohibited except by authorized users?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are Good Documentation Practices followed for changes to records and data, including electronic records?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are audit trails enabled to allow for reconstruction of the course of events relating to the creation, modification, or deletion of an electronic record?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Are records reviewed for accuracy, completeness, and compliance with established procedures and regulations?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': 'Is data maintained securely from the time of creation through disposition after the record’s retention period?', 'answer': '', 'domain': 'Data Integrity', 'type': 'close-ended'}, {'question': "Does audit trail review for electronic data and the frequency with which it's conducted ensure that regulatory requirements are met, appropriate change controls are implemented, and the reliability of the review is verified?", 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are electronic source records retained even when printouts are used to present data?', 'answer': '', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have an established Disaster Recovery Plan (DRP)?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'If yes, does the plan include up to date contact information for Disaster Recovery service providers?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'Provide the date of when the DRP was last reviewed.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Provide the date of when the DRP was last tested.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Does your company have an established Business Continuity Plan (BCP)?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'If no, explain how the business will ensure they can restore operations in case of unforeseen events with minimal impact on the services provided.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'If yes, does the plan include up to date contact information for Business Continuity service providers?', 'answer': '', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'Provide the date of when the BCP was last reviewed.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Provide the date of when the BCP was last tested.', 'answer': '', 'domain': 'Business Continuity', 'type': 'open-ended'}], 'meta_data': {'company_name': 'AbbVie', 'doc_date': None, 'category': 'RFI', 'type': 'PastResponse'}}, 'ingestion_status': <IngestionStatus.PARSED: 'PARSED'>, 'error_message': None}
2025-07-22 13:32:49,915 - __main__                       - INFO     - [4134370656.py:91] - Successfully parsed and stored JSON for document ID 12.
2025-07-22 13:32:49,920 - __main__                       - INFO     - [4134370656.py:51] - Parsing RFI/RFP document: LEXEO GCP service provider audit questionnaire Blank.docx (ID: 14)
2025-07-22 13:32:49,923 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:135] - Generating executive summary...
2025-07-22 13:32:59,560 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:138] - Splitting document into processable chunks...
2025-07-22 13:32:59,561 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:145] - Processing 6 chunks concurrently...
2025-07-22 13:32:59,562 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:102] - 
--- CHUNK SENT TO LLM ---
|  |  |
| --- | --- |
| **Contract Service Provider Questionnaire** | |
| **Service Provider Name** |  |
| **Service Provider Address** |  |
| **Service Provider Contact Name and Title** |  |
| **Service Provider Contact Telephone Number** |  |
| **Service Provider Contact E-mail** |  |
| **Service Provider Contact Signature/Date** |  |

| **Quality Assessment Inquiry** | **Response** | **Comments** |
| --- | --- | --- |
| **General Company Information** | | |
| Describe your company’s general service offerings. | Yes No  N/A  See Attached |  |
| What products or services are or would you be providing to LEXEO? | Yes No  N/A  See Attached |  |
| How many years has your company been in business? | Yes No  N/A  See Attached |  |
| Describe any changes in corporate structure in the last five years (e.g., mergers, acquisitions, Initial Public Offering (IPO)) | Yes No  N/A  See Attached |  |
| Describe any planned/announced changes in corporate structure. | Yes No  N/A  See Attached |  |
| ...
--- END OF CHUNK ---

2025-07-22 13:32:59,567 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:102] - 
--- CHUNK SENT TO LLM ---
See Attached |  |
| Are background and debarment checks performed for new employees? | Yes No  N/A  See Attached |  |
| What GXP and regulatory requirements (e.g., 21 CFR 312) are employees required to be trained on? At what frequency is refresher training required? | Yes No  N/A  See Attached |  |
| Are company personnel specifically trained to ALCOA++ principles for GXP data? | Yes No  N/A  See Attached |  |
| Please provide the Quality Policy, Quality Manual, and a list of Standard Operating Procedures (SOPs). | Yes No  N/A  See Attached |  |
| Please describe your company’s Risk Management program. | Yes No  N/A  See Attached |  |
| If the Quality Management System (QMS) is electronic, please provide the system name, version, and evidence of the most recent validation. | Yes No  N/A  See Attached |  |
| Please provide the procedure for managing QMS documents such as SOPs and Work Instructions (WIs). | Yes No  N/A  See Attached |  |
| Please provide the procedure(s) for conducting i...
--- END OF CHUNK ---

2025-07-22 13:32:59,570 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:102] - 
--- CHUNK SENT TO LLM ---
hed |  |
| Does the system follow the structure of the [TMF reference](https://tmfrefmodel.com/) model? | Yes No  N/A  See Attached |  |
| Are sponsor personnel permitted to access the TMF? Please describe the process. | Yes No  N/A  See Attached |  |
| Is the TMF metadata included in the transfer of the TMF to LEXEO at the end of the study? Please describe the transfer process. | Yes No  N/A  See Attached |  |
| Does the LEXEO TMF undergo ongoing Quality Control? Please describe. | Yes No  N/A  See Attached |  |
| Does the TMF uses validated signatures? | Yes No  N/A  See Attached |  |
| Does your organization incorporate third party vendor documents into the TMF? Please describe the process and QC measures. | Yes No  N/A  See Attached |  |
| Are there any documents that your organization considers to be “Non-TMF” documents? If yes, please describe what they are and how they are managed. | Yes No  N/A  See Attached |  |
| Are regulatory inspectors permitted access to the TMF? If so, p...
--- END OF CHUNK ---

2025-07-22 13:32:59,576 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:102] - 
--- CHUNK SENT TO LLM ---
n for electronic systems? | Yes No  N/A  See Attached |  |
| How are software issues reported by clinical sites or sponsors like LEXEO handled? | Yes No  N/A  See Attached |  |
| How long are help desk tickets retained for? | Yes No  N/A  See Attached |  |
| Does your company use any open-source software? If so, how is this managed and what procedures are in place? | Yes No  N/A  See Attached |  |
| Describe the process used for major and minor software release planning, testing and implementation. | Yes No  N/A  See Attached |  |
| Describe your company’s process for managing system downtime during patches or upgrades. | Yes No  N/A  See Attached |  |
| Describe the process for user training on software. | Yes No  N/A  See Attached |  |
| Are sponsors and regulatory authority inspectors able to access software validation information? | Yes No  N/A  See Attached |  |
| **Privacy/Confidentiality** | | |
| Does your company have a Data Privacy Officer? | Yes No  N/A  See Attached |  |
| ...
--- END OF CHUNK ---

2025-07-22 13:32:59,577 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:102] - 
--- CHUNK SENT TO LLM ---
ncluding radioactive substances and compounding capabilities. | Yes No  N/A  See Attached |  |
| Describe your company’s participation in protocol development and clinical study report writing for sponsors. | Yes No  N/A  See Attached |  |
| What electronic data collection tools are used? Are they validated? | Yes No  N/A  See Attached |  |
| **Safety Oversight** | | |
| Describe the qualifications of personnel reviewing, handling, and assessing adverse events (AEs) and Serious Adverse Events (SAEs). | Yes No  N/A  See Attached |  |
| How are SAEs tracked and reconciled? | Yes No  N/A  See Attached |  |
| What metrics are reported to LEXEO regarding compliance with SAE reporting? | Yes No  N/A  See Attached |  |
| Describe the process for safety signal detection. | Yes No  N/A  See Attached |  |
| Describe the responsibilities and process for medical monitoring. | Yes No  N/A  See Attached |  |
| Identify the system used for safety case management and provide evidence of validation. | ...
--- END OF CHUNK ---

2025-07-22 13:32:59,579 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:102] - 
--- CHUNK SENT TO LLM ---
* | | |
| Does your organization provide regulatory strategy or operations services? | Yes No  N/A  See Attached |  |
| What countries does your organization have expertise in? | Yes No  N/A  See Attached |  |
| Describe procedures used for CTIS and ClinicalTrials.gov | Yes No  N/A  See Attached |  |
| Does your organization provide regulatory publishing or is this outsourced? | Yes No  N/A  See Attached |  |

|  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
| Completed By: |  |  |  |  |  |
| *Service Provider Representative* | Name |  | Title |  | Date |
--- END OF CHUNK ---

2025-07-22 13:33:03,605 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': '', 'qa_pairs': [{'question': 'Does your organization provide regulatory strategy or operations services?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What countries does your organization have expertise in?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Describe procedures used for CTIS and ClinicalTrials.gov', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your organization provide regulatory publishing or is this outsourced?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}], 'meta_data': {'company_name': '', 'date': '', 'category': '', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:33:18,851 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': 'The document is a Contract Service Provider Questionnaire that includes inquiries about general company information, quality assurance, and other related aspects. It is structured in a tabular format where questions are posed with options for responses and comments.', 'qa_pairs': [{'question': 'Describe your company’s general service offerings.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What products or services are or would you be providing to LEXEO?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'How many years has your company been in business?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Describe any changes in corporate structure in the last five years (e.g., mergers, acquisitions, Initial Public Offering (IPO))', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Describe any planned/announced changes in corporate structure.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide the worldwide number of personnel, including contractors/consultants.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide the number of employees, contractors, and consultants in the United States.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide the number of employees, contractors, and consultants in the European Union.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What percentage of your workforce is temporary, contract or consultant?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide a company organization chart that includes the reporting structure for your Quality Department.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What is the rate of employee turnover within the last five years? Which functional area has the highest turnover rate?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Is your company part of a larger group of companies?', 'answer': 'See Attached', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Is your company, parent company(ies), or subsidiaries headquartered outside of the United States? If so, please specify.', 'answer': 'See Attached', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Does your company maintain any licensures or accreditations (e.g., ISO, CAP, CLIA)? If so, please specify, along with expiration date.', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Have any regulatory agencies inspected your company in the past 5 years? If yes, please attach relevant documentation.', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Describe the structure, staffing and responsibilities of your Quality Department.', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Name, Title, and contact information of Quality Department Head', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'What is the lead time for an onsite or remote audit?', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Are written and signed job descriptions available for all roles with GXP responsibilities?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are documented training and qualification requirements available for all GXP roles?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Please provide the procedure for new employee onboarding.', 'answer': 'See Attached', 'domain': 'Human Resources', 'type': 'open-ended'}, {'question': 'Are background and debarment checks performed for new employees?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What GXP and regulatory requirements (e.g., 21 CFR 312) are employees required to be trained on? At what frequency is refresher training required?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Are company personnel specifically trained to ALCOA++ principles for GXP data?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Please provide the Quality Policy, Quality Manual, and a list of Standard Operating Procedures (SOPs).', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Please describe your company’s Risk Management program.', 'answer': 'See Attached', 'domain': 'Risk Management', 'type': 'open-ended'}, {'question': 'If the Quality Management System (QMS) is electronic, please provide the system name, version, and evidence of the most recent validation.', 'answer': 'See Attached', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Please provide the procedure for managing QMS documents such as SOPs and Work Instructions (WIs).', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}], 'meta_data': {'company_name': 'LEXEO', 'date': '', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:33:19,888 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': '', 'qa_pairs': [{'question': 'Including radioactive substances and compounding capabilities.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Describe your company’s participation in protocol development and clinical study report writing for sponsors.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What electronic data collection tools are used? Are they validated?', 'answer': 'See Attached', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Describe the qualifications of personnel reviewing, handling, and assessing adverse events (AEs) and Serious Adverse Events (SAEs).', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'How are SAEs tracked and reconciled?', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'What metrics are reported to LEXEO regarding compliance with SAE reporting?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Describe the process for safety signal detection.', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'Describe the responsibilities and process for medical monitoring.', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'Identify the system used for safety case management and provide evidence of validation.', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'Describe meeting frequency and topics with LEXEO.', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'What time zone is the LEXEO Project Manager (PM) located in?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Describe the study plans that will be developed for the LEXEO project.', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'How are project decisions and communications archived?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'How is project specific training identified, assigned, managed, and archived?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Describe the management of applicable external committees (e.g., safety review, dose escalation, Data Safety Monitoring Board, Blinded Independent Review Committee).', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Describe your processes for onsite, remote, riREMOVEDbased, and centralized monitoring.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe minimum monitor educational and training experience.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe monitoring onboarding and on the job training.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe escalation pathways and strategies for noncompliant sites and protocol deviations.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe how monitors confirm investigators have reviewed safety reports and submitted them to the applicable ethics committee.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe the Electronic Data Capture (EDC) system and provide evidence of validation.', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe the management of coding dictionaries.', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe data transfer processes and controls (incoming and outgoing).', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe procedures and controls for database lock/unlock.', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe version of statistical analysis programs used and describe validation.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe QC procedures for programs.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe management and delivery of datasets.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe procedures for development, review and approval of the Statistical Analysis Plan and outputs.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe templates used.', 'answer': 'See Attached', 'domain': 'Medical Writing', 'type': 'open-ended'}, {'question': 'Describe version control.', 'answer': 'See Attached', 'domain': 'Medical Writing', 'type': 'open-ended'}, {'question': 'Describe review and approval requirements.', 'answer': 'See Attached', 'domain': 'Medical Writing', 'type': 'open-ended'}, {'question': 'Does your organization provide regulatory strategy or operations services?', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'close-ended'}, {'question': 'What countries does your organization have expertise in?', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'open-ended'}, {'question': 'Describe procedures used for CTIS and ClinicalTrials.gov.', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'open-ended'}, {'question': 'Does your organization provide regulatory publishing or is this outsourced?', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'close-ended'}], 'meta_data': {'company_name': 'LEXEO', 'date': 'N/A', 'category': 'RFP', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:33:21,683 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': '', 'qa_pairs': [{'question': 'Are background and debarment checks performed for new employees?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What GXP and regulatory requirements (e.g., 21 CFR 312) are employees required to be trained on? At what frequency is refresher training required?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Are company personnel specifically trained to ALCOA++ principles for GXP data?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Please provide the Quality Policy, Quality Manual, and a list of Standard Operating Procedures (SOPs).', 'answer': 'See Attached', 'domain': 'Quality Management', 'type': 'open-ended'}, {'question': 'Please describe your company’s Risk Management program.', 'answer': 'See Attached', 'domain': 'Risk Management', 'type': 'open-ended'}, {'question': 'If the Quality Management System (QMS) is electronic, please provide the system name, version, and evidence of the most recent validation.', 'answer': 'See Attached', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Please provide the procedure for managing QMS documents such as SOPs and Work Instructions (WIs).', 'answer': 'See Attached', 'domain': 'Quality Management', 'type': 'open-ended'}, {'question': 'Please provide the procedure(s) for conducting internal and external audits and provide the annual audit plans for the last two years.', 'answer': 'See Attached', 'domain': 'Audit', 'type': 'open-ended'}, {'question': 'At what frequency does your company conduct Quality Management Review? Please provide evidence of the last three Quality Management Reviews.', 'answer': 'See Attached', 'domain': 'Quality Management', 'type': 'open-ended'}, {'question': 'Please provide your company’s Quality Issue/Deviation/Corrective and Preventive Action (CAPA)/Customer Complaint/Data Integrity/Serious Breach procedure(s).', 'answer': 'See Attached', 'domain': 'Quality Management', 'type': 'open-ended'}, {'question': 'Does your company’s standard contractual language include reference to Serious Breach and General Data Protection Regulation (GDPR)?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company’s standard contractual language include regulatory compliance language (e.g., GCP, 21 CFR 11)?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Describe your process for selecting, qualifying, and managing vendors.', 'answer': 'See Attached', 'domain': 'Vendor Management', 'type': 'open-ended'}, {'question': 'Please attach audit certificates for any vendors that will be used for LEXEO activities.', 'answer': 'See Attached', 'domain': 'Vendor Management', 'type': 'open-ended'}, {'question': 'Does your company maintain an approved vendors list for vendors with GXP impact?', 'answer': 'See Attached', 'domain': 'Vendor Management', 'type': 'close-ended'}, {'question': 'How does your company archive GXP records and information?', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'open-ended'}, {'question': 'Please describe the retention period for all GXP records and describe the process and required approvals for record destruction.', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'open-ended'}, {'question': 'Does your company have a written procedure for certified copies?', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'close-ended'}, {'question': 'Does your company retain paper copies of GXP records? If yes, please provide details/specifications/floor plans of the archive space, including physical security, fire suppression, protection from water damage and natural disasters.', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'open-ended'}, {'question': 'Who will be responsible for maintenance of LEXEO project documents?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'How will LEXEO project documents be transferred to LEXEO at the conclusion of the project? Please describe all Quality Control (QC) steps that are required prior to transfer.', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Per SOP, who will approve data and reports provided to LEXEO?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Does your organization provide or host a Trial Master File (TMF) for clinical studies? What system and what version is in use?', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Is the TMF validated? Please provide evidence.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'close-ended'}, {'question': 'Does the system follow the structure of the TMF reference model?', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'close-ended'}, {'question': 'Are sponsor personnel permitted to access the TMF? Please describe the process.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Is the TMF metadata included in the transfer of the TMF to LEXEO at the end of the study? Please describe the transfer process.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Does the LEXEO TMF undergo ongoing Quality Control? Please describe.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Does the TMF uses validated signatures?', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'close-ended'}, {'question': 'Does your organization incorporate third party vendor documents into the TMF? Please describe the process and QC measures.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Are there any documents that your organization considers to be “Non-TMF” documents? If yes, please describe what they are and how they are managed.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}], 'meta_data': {'company_name': 'LEXEO', 'date': 'N/A', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:33:22,865 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': '', 'qa_pairs': [{'question': 'How are software issues reported by clinical sites or sponsors like LEXEO handled?', 'answer': 'N/A', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'How long are help desk tickets retained for?', 'answer': 'N/A', 'domain': 'Support', 'type': 'open-ended'}, {'question': 'Does your company use any open-source software? If so, how is this managed and what procedures are in place?', 'answer': 'N/A', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Describe the process used for major and minor software release planning, testing and implementation.', 'answer': 'N/A', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Describe your company’s process for managing system downtime during patches or upgrades.', 'answer': 'N/A', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Describe the process for user training on software.', 'answer': 'N/A', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Are sponsors and regulatory authority inspectors able to access software validation information?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Data Privacy Officer?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company have a Privacy Policy or SOP?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company have assessment and reporting procedures for privacy or confidentiality breaches?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company have procedures in place to segregate and protect unblinded trial data for blinded trials? Please describe.', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'open-ended'}, {'question': 'Does your company have procedures in the event a trial participant withdraws consent?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company maintain, control, and periodically update laboratory reference ranges?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Does your company maintain medical oversight and prompt reporting of critical lab values?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Does your company use validated shippers for shipment of laboratory samples?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Are your personnel trained to laboratory safety, Environmental Health and Safety and IATA standards?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Please provide a facility map/floorplan.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe temperature/environmental monitoring controls in your facility.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe equipment calibration, validation, and preventive maintenance procedures.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe reagent purchase, formulation, QC, and management.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe calibration standard management.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe procedures for sample management and archive, including ongoing reconciliation with the clinical database.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe method validation procedures, including accuracy, linearity, precision, specificity, limit of quantitation, etc.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Describe procedures for trial participant recruitment, including verification of identity and washout from other trials.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe consent procedures.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe arrangement for emergency care.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe medical oversight.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe “house rules” for any in-house portion of a clinical study.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe onsite laboratory capabilities and sample management/shipping process.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe pharmacy capabilities, including radioactive substances and compounding capabilities.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe your company’s participation in protocol development and clinical study report writing for sponsors.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'What electronic data collection tools are used? Are they validated?', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe the qualifications of personnel reviewing, handling, and assessing adverse events (AEs) and Serious Adverse Events (SAEs).', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'How are SAEs tracked and reconciled?', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'What metrics are reported to LEXEO regarding compliance with SAE reporting?', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Describe the process for safety signal detection.', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Describe the responsibilities and process for medical monitoring.', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Identify the system used for safety case management and provide evidence of validation.', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}], 'meta_data': {'company_name': 'LEXEO', 'date': 'N/A', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:33:23,468 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:106] - 
--- LLM RESPONSE FOR CHUNK ---
{'summary': '', 'description': '', 'qa_pairs': [{'question': 'Does the system follow the structure of the TMF reference model?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are sponsor personnel permitted to access the TMF? Please describe the process.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Is the TMF metadata included in the transfer of the TMF to LEXEO at the end of the study? Please describe the transfer process.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does the LEXEO TMF undergo ongoing Quality Control? Please describe.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does the TMF use validated signatures?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your organization incorporate third party vendor documents into the TMF? Please describe the process and QC measures.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': "Are there any documents that your organization considers to be 'Non-TMF' documents? If yes, please describe what they are and how they are managed.", 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Are regulatory inspectors permitted access to the TMF? If so, please describe the process.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your organization maintain business continuity/disaster recovery plans?', 'answer': 'N/A', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'At what frequency are these plans tested? Are tests performed desktop only? Please attach the last three tests.', 'answer': 'N/A', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Describe physical security for your facility, including frequency of user access review.', 'answer': 'N/A', 'domain': 'Security', 'type': 'open-ended'}, {'question': 'Do you have a pest control vendor? What is the frequency of checks?', 'answer': 'N/A', 'domain': 'Facility Management', 'type': 'open-ended'}, {'question': 'Does your facility have access to backup power in the event of a power outage? For how many days?', 'answer': 'N/A', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'What percentage of employees are in office versus remote?', 'answer': 'N/A', 'domain': 'Human Resources', 'type': 'open-ended'}, {'question': 'Are logical security controls in place for electronic systems? Please describe.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'How often are user access reviews conducted for company electronic systems?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Please provide the Recovery Time Objective (RTO) and Recovery Point Objective (RPO) for any electronic systems that will apply to the LEXEO project.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Has your company certified to FDA per 21 CFR 11.100 that electronic signatures are in use?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What system(s) does your company use for electronic signatures? How was it validated?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Is multifactor authentication (MFA) required to access company systems?', 'answer': 'N/A', 'domain': 'Security', 'type': 'close-ended'}, {'question': 'How frequently are password changes forced?', 'answer': 'N/A', 'domain': 'Security', 'type': 'open-ended'}, {'question': 'Does your company maintain a list of electronic systems with GXP impact? How often are systems reviewed?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'What systems would house LEXEO data and information?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'In what geographies (e.g., EU, USA) will LEXEO data be stored?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Does your company develop and validate computerized systems? What SOPs support this activity?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe how your company assesses and implements commercial off-the-shelf (COTS) software.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Are audit trails available for all GXP systems? Does your firm have procedures for review of audit trails based on system and data risk?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your company use GAMP 5Ò classification for electronic systems?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'close-ended'}, {'question': 'How are software issues reported by clinical sites or sponsors like LEXEO handled?', 'answer': 'N/A', 'domain': 'Support', 'type': 'open-ended'}, {'question': 'How long are help desk tickets retained for?', 'answer': 'N/A', 'domain': 'Support', 'type': 'open-ended'}, {'question': 'Does your company use any open-source software? If so, how is this managed and what procedures are in place?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe the process used for major and minor software release planning, testing and implementation.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe your company’s process for managing system downtime during patches or upgrades.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe the process for user training on software.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Are sponsors and regulatory authority inspectors able to access software validation information?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Data Privacy Officer?', 'answer': 'N/A', 'domain': 'Privacy/Confidentiality', 'type': 'close-ended'}], 'meta_data': {'company_name': 'LEXEO', 'date': 'N/A', 'category': 'RFI', 'type': 'PastResponse'}}
--- END OF LLM RESPONSE ---

2025-07-22 13:33:23,470 - rfiprocessor.core.agents.rfi_parser - INFO     - [rfi_parser.py:191] - Successfully parsed document. Found 157 Q&A pairs.
2025-07-22 13:33:23,475 - __main__                       - INFO     - [4134370656.py:67] - Saved parsed output to json_output\LEXEO GCP service provider audit questionnaire Blank.json
2025-07-22 13:33:23,477 - __main__                       - INFO     - [4134370656.py:73] - Successfully validated JSON structure for doc ID 14.
2025-07-22 13:33:23,480 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 14 with: {'rfi_json_payload': {'summary': '## Solution Overview\nOur proposed solution leverages cutting-edge technology to enhance operational efficiency and drive innovation in the life sciences sector. By integrating advanced analytics and machine learning, we provide a robust platform that supports data-driven decision-making. The solution is designed to be scalable, ensuring it meets both current and future needs of the organization.\n\n## Technical Capabilities\nThe platform offers seamless integration with existing systems, ensuring minimal disruption during deployment. It is built on a secure, cloud-based architecture that provides high availability and redundancy. Our solution supports a wide range of data formats and includes powerful tools for data visualization and reporting, enabling users to gain insights quickly and effectively.\n\n## Regulatory Compliance\nWe prioritize compliance with all relevant industry regulations, including HIPAA, GDPR, and 21 CFR Part 11. Our solution includes comprehensive audit trails and data encryption to ensure the highest levels of data security and privacy. Regular updates are provided to maintain compliance with evolving regulatory requirements.\n\n## Implementation Timeline\nThe implementation process is structured to ensure a smooth transition and is typically completed within 12 to 16 weeks. Our dedicated project management team works closely with your organization to ensure all milestones are met on time. Post-implementation, we offer extensive training to ensure users are fully equipped to utilize the platform effectively.\n\n## Key Differentiators\nOur solution stands out due to its user-friendly interface, which requires minimal training for effective use. The platform’s ability to integrate with a wide range of third-party applications sets it apart from competitors. Additionally, our commitment to customer service ensures that clients receive ongoing support and customization as needed.\n\n## Support and Maintenance\nWe provide 24/7 customer support with a dedicated team of experts ready to assist with any technical issues. Our maintenance package includes regular software updates and performance monitoring to ensure optimal system functionality. Clients also have access to an extensive knowledge base and user community for additional support resources.\n\nCompany Name: Cogstate', 'description': 'The document is a Contract Service Provider Questionnaire that includes inquiries about general company information, quality assurance, and other related aspects. It is structured in a tabular format where questions are posed with options for responses and comments.', 'qa_pairs': [{'question': 'Describe your company’s general service offerings.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What products or services are or would you be providing to LEXEO?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'How many years has your company been in business?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Describe any changes in corporate structure in the last five years (e.g., mergers, acquisitions, Initial Public Offering (IPO))', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Describe any planned/announced changes in corporate structure.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide the worldwide number of personnel, including contractors/consultants.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide the number of employees, contractors, and consultants in the United States.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide the number of employees, contractors, and consultants in the European Union.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What percentage of your workforce is temporary, contract or consultant?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Please provide a company organization chart that includes the reporting structure for your Quality Department.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What is the rate of employee turnover within the last five years? Which functional area has the highest turnover rate?', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Is your company part of a larger group of companies?', 'answer': 'See Attached', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Is your company, parent company(ies), or subsidiaries headquartered outside of the United States? If so, please specify.', 'answer': 'See Attached', 'domain': 'General', 'type': 'close-ended'}, {'question': 'Does your company maintain any licensures or accreditations (e.g., ISO, CAP, CLIA)? If so, please specify, along with expiration date.', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Have any regulatory agencies inspected your company in the past 5 years? If yes, please attach relevant documentation.', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Describe the structure, staffing and responsibilities of your Quality Department.', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Name, Title, and contact information of Quality Department Head', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'What is the lead time for an onsite or remote audit?', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Are written and signed job descriptions available for all roles with GXP responsibilities?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are documented training and qualification requirements available for all GXP roles?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Please provide the procedure for new employee onboarding.', 'answer': 'See Attached', 'domain': 'Human Resources', 'type': 'open-ended'}, {'question': 'Are background and debarment checks performed for new employees?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What GXP and regulatory requirements (e.g., 21 CFR 312) are employees required to be trained on? At what frequency is refresher training required?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Are company personnel specifically trained to ALCOA++ principles for GXP data?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Please provide the Quality Policy, Quality Manual, and a list of Standard Operating Procedures (SOPs).', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Please describe your company’s Risk Management program.', 'answer': 'See Attached', 'domain': 'Risk Management', 'type': 'open-ended'}, {'question': 'If the Quality Management System (QMS) is electronic, please provide the system name, version, and evidence of the most recent validation.', 'answer': 'See Attached', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Please provide the procedure for managing QMS documents such as SOPs and Work Instructions (WIs).', 'answer': 'See Attached', 'domain': 'Quality Assurance', 'type': 'open-ended'}, {'question': 'Please provide the procedure(s) for conducting internal and external audits and provide the annual audit plans for the last two years.', 'answer': 'See Attached', 'domain': 'Audit', 'type': 'open-ended'}, {'question': 'At what frequency does your company conduct Quality Management Review? Please provide evidence of the last three Quality Management Reviews.', 'answer': 'See Attached', 'domain': 'Quality Management', 'type': 'open-ended'}, {'question': 'Please provide your company’s Quality Issue/Deviation/Corrective and Preventive Action (CAPA)/Customer Complaint/Data Integrity/Serious Breach procedure(s).', 'answer': 'See Attached', 'domain': 'Quality Management', 'type': 'open-ended'}, {'question': 'Does your company’s standard contractual language include reference to Serious Breach and General Data Protection Regulation (GDPR)?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company’s standard contractual language include regulatory compliance language (e.g., GCP, 21 CFR 11)?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Describe your process for selecting, qualifying, and managing vendors.', 'answer': 'See Attached', 'domain': 'Vendor Management', 'type': 'open-ended'}, {'question': 'Please attach audit certificates for any vendors that will be used for LEXEO activities.', 'answer': 'See Attached', 'domain': 'Vendor Management', 'type': 'open-ended'}, {'question': 'Does your company maintain an approved vendors list for vendors with GXP impact?', 'answer': 'See Attached', 'domain': 'Vendor Management', 'type': 'close-ended'}, {'question': 'How does your company archive GXP records and information?', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'open-ended'}, {'question': 'Please describe the retention period for all GXP records and describe the process and required approvals for record destruction.', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'open-ended'}, {'question': 'Does your company have a written procedure for certified copies?', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'close-ended'}, {'question': 'Does your company retain paper copies of GXP records? If yes, please provide details/specifications/floor plans of the archive space, including physical security, fire suppression, protection from water damage and natural disasters.', 'answer': 'See Attached', 'domain': 'Records Management', 'type': 'open-ended'}, {'question': 'Who will be responsible for maintenance of LEXEO project documents?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'How will LEXEO project documents be transferred to LEXEO at the conclusion of the project? Please describe all Quality Control (QC) steps that are required prior to transfer.', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Per SOP, who will approve data and reports provided to LEXEO?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Does your organization provide or host a Trial Master File (TMF) for clinical studies? What system and what version is in use?', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Is the TMF validated? Please provide evidence.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'close-ended'}, {'question': 'Does the system follow the structure of the TMF reference model?', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'close-ended'}, {'question': 'Are sponsor personnel permitted to access the TMF? Please describe the process.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Is the TMF metadata included in the transfer of the TMF to LEXEO at the end of the study? Please describe the transfer process.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Does the LEXEO TMF undergo ongoing Quality Control? Please describe.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Does the TMF uses validated signatures?', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'close-ended'}, {'question': 'Does your organization incorporate third party vendor documents into the TMF? Please describe the process and QC measures.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Are there any documents that your organization considers to be “Non-TMF” documents? If yes, please describe what they are and how they are managed.', 'answer': 'See Attached', 'domain': 'Clinical Studies', 'type': 'open-ended'}, {'question': 'Does the system follow the structure of the TMF reference model?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Are sponsor personnel permitted to access the TMF? Please describe the process.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Is the TMF metadata included in the transfer of the TMF to LEXEO at the end of the study? Please describe the transfer process.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does the LEXEO TMF undergo ongoing Quality Control? Please describe.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does the TMF use validated signatures?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your organization incorporate third party vendor documents into the TMF? Please describe the process and QC measures.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': "Are there any documents that your organization considers to be 'Non-TMF' documents? If yes, please describe what they are and how they are managed.", 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Are regulatory inspectors permitted access to the TMF? If so, please describe the process.', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your organization maintain business continuity/disaster recovery plans?', 'answer': 'N/A', 'domain': 'Business Continuity', 'type': 'close-ended'}, {'question': 'At what frequency are these plans tested? Are tests performed desktop only? Please attach the last three tests.', 'answer': 'N/A', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'Describe physical security for your facility, including frequency of user access review.', 'answer': 'N/A', 'domain': 'Security', 'type': 'open-ended'}, {'question': 'Do you have a pest control vendor? What is the frequency of checks?', 'answer': 'N/A', 'domain': 'Facility Management', 'type': 'open-ended'}, {'question': 'Does your facility have access to backup power in the event of a power outage? For how many days?', 'answer': 'N/A', 'domain': 'Business Continuity', 'type': 'open-ended'}, {'question': 'What percentage of employees are in office versus remote?', 'answer': 'N/A', 'domain': 'Human Resources', 'type': 'open-ended'}, {'question': 'Are logical security controls in place for electronic systems? Please describe.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'How often are user access reviews conducted for company electronic systems?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Please provide the Recovery Time Objective (RTO) and Recovery Point Objective (RPO) for any electronic systems that will apply to the LEXEO project.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Has your company certified to FDA per 21 CFR 11.100 that electronic signatures are in use?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What system(s) does your company use for electronic signatures? How was it validated?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Is multifactor authentication (MFA) required to access company systems?', 'answer': 'N/A', 'domain': 'Security', 'type': 'close-ended'}, {'question': 'How frequently are password changes forced?', 'answer': 'N/A', 'domain': 'Security', 'type': 'open-ended'}, {'question': 'Does your company maintain a list of electronic systems with GXP impact? How often are systems reviewed?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'What systems would house LEXEO data and information?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'In what geographies (e.g., EU, USA) will LEXEO data be stored?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Does your company develop and validate computerized systems? What SOPs support this activity?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe how your company assesses and implements commercial off-the-shelf (COTS) software.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Are audit trails available for all GXP systems? Does your firm have procedures for review of audit trails based on system and data risk?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your company use GAMP 5Ò classification for electronic systems?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'close-ended'}, {'question': 'How are software issues reported by clinical sites or sponsors like LEXEO handled?', 'answer': 'N/A', 'domain': 'Support', 'type': 'open-ended'}, {'question': 'How long are help desk tickets retained for?', 'answer': 'N/A', 'domain': 'Support', 'type': 'open-ended'}, {'question': 'Does your company use any open-source software? If so, how is this managed and what procedures are in place?', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe the process used for major and minor software release planning, testing and implementation.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe your company’s process for managing system downtime during patches or upgrades.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Describe the process for user training on software.', 'answer': 'N/A', 'domain': 'Information Technology', 'type': 'open-ended'}, {'question': 'Are sponsors and regulatory authority inspectors able to access software validation information?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Does your company have a Data Privacy Officer?', 'answer': 'N/A', 'domain': 'Privacy/Confidentiality', 'type': 'close-ended'}, {'question': 'Does your company have a Privacy Policy or SOP?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company have assessment and reporting procedures for privacy or confidentiality breaches?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company have procedures in place to segregate and protect unblinded trial data for blinded trials? Please describe.', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'open-ended'}, {'question': 'Does your company have procedures in the event a trial participant withdraws consent?', 'answer': 'N/A', 'domain': 'Privacy', 'type': 'close-ended'}, {'question': 'Does your company maintain, control, and periodically update laboratory reference ranges?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Does your company maintain medical oversight and prompt reporting of critical lab values?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Does your company use validated shippers for shipment of laboratory samples?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Are your personnel trained to laboratory safety, Environmental Health and Safety and IATA standards?', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'close-ended'}, {'question': 'Please provide a facility map/floorplan.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe temperature/environmental monitoring controls in your facility.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe equipment calibration, validation, and preventive maintenance procedures.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe reagent purchase, formulation, QC, and management.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe calibration standard management.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe procedures for sample management and archive, including ongoing reconciliation with the clinical database.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Please describe method validation procedures, including accuracy, linearity, precision, specificity, limit of quantitation, etc.', 'answer': 'N/A', 'domain': 'Laboratory Services', 'type': 'open-ended'}, {'question': 'Describe procedures for trial participant recruitment, including verification of identity and washout from other trials.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe consent procedures.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe arrangement for emergency care.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe medical oversight.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe “house rules” for any in-house portion of a clinical study.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe onsite laboratory capabilities and sample management/shipping process.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe pharmacy capabilities, including radioactive substances and compounding capabilities.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe your company’s participation in protocol development and clinical study report writing for sponsors.', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'What electronic data collection tools are used? Are they validated?', 'answer': 'N/A', 'domain': 'Phase I Unit services', 'type': 'open-ended'}, {'question': 'Describe the qualifications of personnel reviewing, handling, and assessing adverse events (AEs) and Serious Adverse Events (SAEs).', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'How are SAEs tracked and reconciled?', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'What metrics are reported to LEXEO regarding compliance with SAE reporting?', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Describe the process for safety signal detection.', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Describe the responsibilities and process for medical monitoring.', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Identify the system used for safety case management and provide evidence of validation.', 'answer': 'N/A', 'domain': 'Safety Oversight', 'type': 'open-ended'}, {'question': 'Including radioactive substances and compounding capabilities.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'Describe your company’s participation in protocol development and clinical study report writing for sponsors.', 'answer': 'See Attached', 'domain': 'General', 'type': 'open-ended'}, {'question': 'What electronic data collection tools are used? Are they validated?', 'answer': 'See Attached', 'domain': 'Technology', 'type': 'open-ended'}, {'question': 'Describe the qualifications of personnel reviewing, handling, and assessing adverse events (AEs) and Serious Adverse Events (SAEs).', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'How are SAEs tracked and reconciled?', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'What metrics are reported to LEXEO regarding compliance with SAE reporting?', 'answer': 'See Attached', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Describe the process for safety signal detection.', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'Describe the responsibilities and process for medical monitoring.', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'Identify the system used for safety case management and provide evidence of validation.', 'answer': 'See Attached', 'domain': 'Safety', 'type': 'open-ended'}, {'question': 'Describe meeting frequency and topics with LEXEO.', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'What time zone is the LEXEO Project Manager (PM) located in?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Describe the study plans that will be developed for the LEXEO project.', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'How are project decisions and communications archived?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'How is project specific training identified, assigned, managed, and archived?', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Describe the management of applicable external committees (e.g., safety review, dose escalation, Data Safety Monitoring Board, Blinded Independent Review Committee).', 'answer': 'See Attached', 'domain': 'Project Management', 'type': 'open-ended'}, {'question': 'Describe your processes for onsite, remote, riREMOVEDbased, and centralized monitoring.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe minimum monitor educational and training experience.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe monitoring onboarding and on the job training.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe escalation pathways and strategies for noncompliant sites and protocol deviations.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe how monitors confirm investigators have reviewed safety reports and submitted them to the applicable ethics committee.', 'answer': 'See Attached', 'domain': 'Monitoring', 'type': 'open-ended'}, {'question': 'Describe the Electronic Data Capture (EDC) system and provide evidence of validation.', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe the management of coding dictionaries.', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe data transfer processes and controls (incoming and outgoing).', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe procedures and controls for database lock/unlock.', 'answer': 'See Attached', 'domain': 'Data Management', 'type': 'open-ended'}, {'question': 'Describe version of statistical analysis programs used and describe validation.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe QC procedures for programs.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe management and delivery of datasets.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe procedures for development, review and approval of the Statistical Analysis Plan and outputs.', 'answer': 'See Attached', 'domain': 'Statistical Analysis and Programming', 'type': 'open-ended'}, {'question': 'Describe templates used.', 'answer': 'See Attached', 'domain': 'Medical Writing', 'type': 'open-ended'}, {'question': 'Describe version control.', 'answer': 'See Attached', 'domain': 'Medical Writing', 'type': 'open-ended'}, {'question': 'Describe review and approval requirements.', 'answer': 'See Attached', 'domain': 'Medical Writing', 'type': 'open-ended'}, {'question': 'Does your organization provide regulatory strategy or operations services?', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'close-ended'}, {'question': 'What countries does your organization have expertise in?', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'open-ended'}, {'question': 'Describe procedures used for CTIS and ClinicalTrials.gov.', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'open-ended'}, {'question': 'Does your organization provide regulatory publishing or is this outsourced?', 'answer': 'See Attached', 'domain': 'Regulatory', 'type': 'close-ended'}, {'question': 'Does your organization provide regulatory strategy or operations services?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'What countries does your organization have expertise in?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}, {'question': 'Describe procedures used for CTIS and ClinicalTrials.gov', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'open-ended'}, {'question': 'Does your organization provide regulatory publishing or is this outsourced?', 'answer': 'N/A', 'domain': 'Compliance', 'type': 'close-ended'}], 'meta_data': {'company_name': 'LEXEO', 'doc_date': None, 'category': 'RFI', 'type': 'PastResponse'}}, 'ingestion_status': <IngestionStatus.PARSED: 'PARSED'>, 'error_message': None}
2025-07-22 13:33:23,488 - __main__                       - INFO     - [4134370656.py:91] - Successfully parsed and stored JSON for document ID 14.
2025-07-22 13:33:23,492 - __main__                       - INFO     - [4134370656.py:103] - --- Ingestion Pipeline Finished ---
2025-07-22 13:33:23,493 - __main__                       - INFO     - [4134370656.py:110] - Application finished.
2025-07-22 13:33:23,563 - rfiprocessor.services.chunker  - INFO     - [chunker.py:30] - ChunkerService initialized with chunk_size=2000 and chunk_overlap=200
2025-07-22 13:33:23,569 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 3 (Type: RFI/RFP)
2025-07-22 13:33:23,570 - rfiprocessor.services.chunker  - INFO     - [chunker.py:80] - Created 135 Q&A-based chunks for document ID 3.
2025-07-22 13:33:23,590 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:126] - Added 135 chunks to document ID 3.
2025-07-22 13:33:23,633 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 3 with: {'ingestion_status': <IngestionStatus.CHUNKED: 'CHUNKED'>}
2025-07-22 13:33:23,636 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 5 (Type: Supporting Document)
2025-07-22 13:33:23,637 - rfiprocessor.services.chunker  - WARNING  - [chunker.py:88] - Markdown content for document ID 5 is empty. Skipping chunking.
2025-07-22 13:33:23,654 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 6 (Type: Supporting Document)
2025-07-22 13:33:23,656 - rfiprocessor.services.chunker  - INFO     - [chunker.py:107] - Created 2 semantic chunks for document ID 6.
2025-07-22 13:33:23,665 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:126] - Added 2 chunks to document ID 6.
2025-07-22 13:33:23,670 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 6 with: {'ingestion_status': <IngestionStatus.CHUNKED: 'CHUNKED'>}
2025-07-22 13:33:23,676 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 7 (Type: Supporting Document)
2025-07-22 13:33:23,678 - rfiprocessor.services.chunker  - WARNING  - [chunker.py:88] - Markdown content for document ID 7 is empty. Skipping chunking.
2025-07-22 13:33:23,681 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 9 (Type: RFI/RFP)
2025-07-22 13:33:23,682 - rfiprocessor.services.chunker  - INFO     - [chunker.py:80] - Created 87 Q&A-based chunks for document ID 9.
2025-07-22 13:33:23,696 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:126] - Added 87 chunks to document ID 9.
2025-07-22 13:33:23,734 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 9 with: {'ingestion_status': <IngestionStatus.CHUNKED: 'CHUNKED'>}
2025-07-22 13:33:23,738 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 10 (Type: RFI/RFP)
2025-07-22 13:33:23,739 - rfiprocessor.services.chunker  - INFO     - [chunker.py:80] - Created 47 Q&A-based chunks for document ID 10.
2025-07-22 13:33:23,751 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:126] - Added 47 chunks to document ID 10.
2025-07-22 13:33:23,773 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 10 with: {'ingestion_status': <IngestionStatus.CHUNKED: 'CHUNKED'>}
2025-07-22 13:33:23,779 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 12 (Type: RFI/RFP)
2025-07-22 13:33:23,780 - rfiprocessor.services.chunker  - INFO     - [chunker.py:80] - Created 122 Q&A-based chunks for document ID 12.
2025-07-22 13:33:23,794 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:126] - Added 122 chunks to document ID 12.
2025-07-22 13:33:23,847 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 12 with: {'ingestion_status': <IngestionStatus.CHUNKED: 'CHUNKED'>}
2025-07-22 13:33:23,857 - rfiprocessor.services.chunker  - INFO     - [chunker.py:44] - Creating chunks for document ID 14 (Type: RFI/RFP)
2025-07-22 13:33:23,860 - rfiprocessor.services.chunker  - INFO     - [chunker.py:80] - Created 157 Q&A-based chunks for document ID 14.
2025-07-22 13:33:23,876 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:126] - Added 157 chunks to document ID 14.
2025-07-22 13:33:23,925 - rfiprocessor.services.db_handler - INFO     - [db_handler.py:88] - Updating document ID 14 with: {'ingestion_status': <IngestionStatus.CHUNKED: 'CHUNKED'>}
2025-07-22 13:33:23,945 - __main__                       - INFO     - [1262289274.py:79] - Application started.
2025-07-22 13:33:23,946 - rfiprocessor.db.database       - INFO     - [database.py:34] - Initializing database and creating tables if they don't exist...
2025-07-22 13:33:23,950 - rfiprocessor.db.database       - INFO     - [database.py:41] - Database initialization complete.
